ABSTRACT
Giant cell arteritis is a challenging diagnosis for patients given the high prevalence of negative temporal artery biopsies (TAB). Despite the lack of histopathological evidence of giant cell arteritis in the TAB, patients can still have TAB-negative giant cell arteritis. The purpose of this paper is to analyse the predictors for TAB-negative giant cell arteritis and the alternative diagnosis of biopsy-negative patients without a giant cell arteritis diagnosis. A retrospective electronic database review of all TABs performed at the Royal Victorian Eye and Ear Hospital from February 2015 to May 2020. Logistic regression analysis was performed to determine predictive factors for a diagnosis of TAB-negative giant cell arteritis. In all cases, a clinical diagnosis of TAB-negative giant cell arteritis was determined by a neuro-ophthalmologist. Alternative diagnoses for negative TABs were identified and explored. A total of 368 TABs were analysed with 287 (78%) negative for histopathological evidence of GCA. Twenty-seven (9.4%) patients were diagnosed and treated as TAB-negative giant cell arteritis. The clinical predictors of a TAB-negative giant cell arteritis diagnosis were the presence of jaw claudication (OR 2.77, 95% CI 1.10-6.98) and CRP (OR 1.02, 95% CI 1.00-1.03). Alternative diagnoses included non-specific headache, non-arteritic anterior ischaemic optic neuropathy, retinal vessel occlusions, and ocular nerve palsies. Predictive factors for a diagnosis of TAB-negative giant cell arteritis were jaw claudication and an elevated CRP. Several alternative diagnoses can be considered for patients with a negative TAB in a neuro-ophthalmology context.
ABSTRACT
BACKGROUND: To examine whether the clinical performance of predicting late age-related macular degeneration (AMD) development is improved through using multimodal imaging (MMI) compared to using colour fundus photography (CFP) alone, and how this compares with a basic prediction model using well-established AMD risk factors. METHODS: Individuals with AMD in this study underwent MMI, including optical coherence tomography (OCT), fundus autofluorescence, near-infrared reflectance and CFP at baseline, and then at 6-monthly intervals for 3-years to determine MMI-defined late AMD development. Four retinal specialists independently assessed the likelihood that each eye at baseline would progress to MMI-defined late AMD over 3-years with CFP, and then with MMI. Predictive performance with CFP and MMI were compared to each other, and to a basic prediction model using age, presence of pigmentary abnormalities, and OCT-based drusen volume. RESULTS: The predictive performance of the clinicians using CFP [AUC = 0.75; 95% confidence interval (CI) = 0.68-0.82] improved when using MMI (AUC = 0.79; 95% CI = 0.72-0.85; p = 0.034). However, a basic prediction model outperformed clinicians using either CFP or MMI (AUC = 0.85; 95% CI = 0.78-91; p ≤ 0.002). CONCLUSIONS: Clinical performance for predicting late AMD development was improved by using MMI compared to CFP. However, a basic prediction model using well-established AMD risk factors outperformed retinal specialists, suggesting that such a model could further improve personalised counselling and monitoring of individuals with the early stages of AMD in clinical practice.
ABSTRACT
PURPOSE: To present a case of frosted branch angiitis associated with an exacerbation of mixed connective tissue disease (MCTD). METHODS: Single case report. RESULTS: A 31-year-old woman presented with a flare of her long-standing MCTD after a change in her immunosuppressive medications. She developed blurred vision and floaters first in the left eye but eventually in both eyes. Fundoscopy showed patchy perivascular sheathing of tertiary branch venules surrounded by retinal hemorrhages characterized as frosted branch angiitis. The patient's MCTD symptoms and retinal vasculitis improved with continued immunosuppressive therapy. At 1-month follow-up, her visual acuity had improved to 20/20 bilaterally with complete resolution on fundoscopy. CONCLUSION: To the authors' knowledge, this is the first report of frosted branch angiitis seen in association with MCTD. The improvement in the patient's visual acuity and fundoscopic findings in this case supports the role of immunosuppressive therapy to treat secondary frosted branch angiitis associated with an autoimmune condition such as MCTD. However, it is recommended that a comprehensive medical workup is performed to exclude an infective cause, particularly in immunocompromised patients.
Subject(s)
Mixed Connective Tissue Disease , Retinal Vasculitis , Female , Humans , Adult , Mixed Connective Tissue Disease/complications , Mixed Connective Tissue Disease/diagnosis , Fluorescein Angiography , Retinal Vasculitis/diagnosis , Retinal Vasculitis/etiology , Retinal Vasculitis/drug therapyABSTRACT
Age-related macular degeneration is an increasingly important public health issue due to ageing populations and increased longevity. Age-related macular degeneration affects individuals older than 55 years and threatens high-acuity central vision required for important tasks such as reading, driving, and recognising faces. Advances in retinal imaging have identified biomarkers of progression to late age-related macular degeneration. New treatments for neovascular age-related macular degeneration offer potentially longer-lasting effects, and progress is being made towards a treatment for atrophic late age-related macular degeneration. An effective intervention to slow progression in the earlier stages of disease, or to prevent late age-related macular degeneration development remains elusive, and our understanding of underlying mechanistic pathways continues to evolve.
Subject(s)
Macular Degeneration , Humans , Middle Aged , Macular Degeneration/diagnosis , Macular Degeneration/therapy , Aging , Visual AcuityABSTRACT
It is indisputable that human activities have caused climate change and that, if left unchecked, these activities will lead to worsening of weather extremes including fire, drought, and flood with all their attendant human suffering. Reducing future climate change requires limiting cumulative emissions of CO2 and other greenhouse gases including methane. We have written this evidence-based perspective to highlight interventions with the largest effect to help the average ophthalmologist make the changes with the highest impact in their day-to-day lives.
Subject(s)
Climate Change , Ophthalmologists , Carbon Dioxide , Humans , MethaneABSTRACT
AIM: To report 4 cases of Cryptococcus gattii (C. gattii) species complex infection with diverse ophthalmic manifestations, and to review the literature to examine pathobiology of disease, classical ophthalmic presentations and outcomes, and treatment modalities for this emerging pathogen. METHODS: Cases of C. gattii meningoencephalitis with ophthalmic manifestations were identified via chart review at two institutions in Australia and one institution in the mid-west region of the United States and are reported as a case series. Additionally, a MEDLINE literature review was conducted to identify all reported cases of C. gattii with ophthalmic manifestations from 1990-2020. Cases were reviewed and tabulated, together with our series of patients, in this report. RESULTS: Four cases of C. gattii with ophthalmic manifestations are presented; three from Australia and one from the USA. A literature review identified a total of 331 cases of C. gattii with visual sequelae. The majority of cases occurred in immunocompetent individuals. Blurred vision and diplopia were the most common presenting symptoms, with papilloedema the most common sign, reported in 10%-50% of cases. Visual loss was reported in 10%-53% of cases, as compared to rates of visual loss of 1%-9% in C. neoformans infection. Elevated intracranial pressure, cerebrospinal fluid (CSF) fungal burden, and abnormal neurological exam at presentation correlated with poor visual outcomes. The mainstays of treatment are anti-fungal agents and aggressive management of intracranial hypertension with serial lumbar punctures. CSF diversion procedures should be considered for refractory cases. Acetazolamide and mannitol are associated with high complication rates, and adjuvant corticosteroids have demonstrated higher mortality rates; these treatments should be avoided. CONCLUSION: Permanent visual loss represents a devastating yet potentially preventable sequelae of C. gattii infection. Intracranial hypertension needs to be recognised early and aggressively managed. Referral to an ophthalmologist/neuro-ophthalmologist in all cases of cryptococcal infection independent of visual symptoms at time of diagnosis is recommended.
ABSTRACT
X-linked retinoschisis (XLRS) is an inherited retinal condition that leads to schisis of the retina. In the past, treatment trials for XLRS have generally used OCT monitoring of the schitic cavities as the primary structural outcome measure and best corrected visual acuity as the primary functional outcome. Here, we report two cases of genetically confirmed XLRS with marked fluctuations in OCT morphology in the absence of treatment. Given this demonstration of spontaneous fluctuation in retinal structure on OCT in XLRS we suggest that alternative measures of retinal function should be used in future therapeutic trials in XLRS.
Subject(s)
Eye Proteins/genetics , Polymorphism, Single Nucleotide/genetics , Retina/physiopathology , Retinoschisis/genetics , Retinoschisis/physiopathology , Child , Electroretinography , Genetic Testing , Humans , Male , Remission, Spontaneous , Retina/diagnostic imaging , Retinoschisis/diagnostic imaging , Tomography, Optical Coherence , Visual Acuity/physiology , Young AdultSubject(s)
Consumer Product Safety , Eye Injuries/etiology , Adult , Elasticity , Eye Injuries/diagnosis , Female , Humans , Male , Victoria , Visual AcuityABSTRACT
BACKGROUND: Anti-acetylcholine receptor antibody (AChR-Abs) testing is a safe and simple ancillary method for confirming the diagnosis of myasthenia gravis. Despite the test's high sensitivity (85%-90%) for generalized myasthenia gravis, AChR-Abs testing has been reported to have a low sensitivity 44%-66% for ocular myasthenia gravis (OMG). The aim of the study is to assess the effectiveness of AChR binding Abs testing for diagnosing OMG by evaluating the test's sensitivity, specificity, positive predictive value, and negative predictive value. METHODS: A retrospective chart review on 114 OMG suspects who presented to the emergency department of a tertiary eye center in Victoria, Australia, was completed. The patients presented with diplopia alone, ptosis alone, or the combination of diplopia and ptosis. All participants were followed up longitudinally in the neuro-ophthalmology outpatient clinics for the average of 2.8 months, where they have received AChR binding testing. The final diagnosis was only given to the patients who either were seropositive for AChR binding Abs and had a high clinical suspicion of OMG, or the patient who was seronegative for AChR binding Abs but was regarded as likely to have OMG clinically and responded to the diagnostic treatments (pyridostigmine bromide and immunosuppressant therapy). RESULTS: The sensitivity of AChR binding Abs testing in diagnosing OMG was higher (80%; 95% confidence interval [CI], 51.91%-95.67%) than previously reported (44%-66%). AChR binding Abs testing also had a high specificity (98.99%; 95% CI, 94.50%-99.97%) and positive predictive value (92.31%; 95% CI, 62.68%-98.85%). CONCLUSION: The study suggests the higher utility of the AChR binding Abs testing in diagnosing OMG due to its high sensitivity, specificity, and positive predictive value.
Subject(s)
Blepharoptosis , Myasthenia Gravis , Autoantibodies , Blepharoptosis/diagnosis , Humans , Myasthenia Gravis/drug therapy , Receptors, Cholinergic , Retrospective StudiesABSTRACT
The ribosome is an evolutionarily conserved organelle essential for cellular function. Ribosome construction requires assembly of approximately 80 different ribosomal proteins (RPs) and four different species of rRNA. As RPs co-assemble into one multi-subunit complex, mutation of the genes that encode RPs might be expected to give rise to phenocopies, in which the same phenotype is associated with loss-of-function of each individual gene. However, a more complex picture is emerging in which, in addition to a group of shared phenotypes, diverse RP gene-specific phenotypes are observed. Here we report the first two mouse mutations (Rps7(Mtu) and Rps7(Zma)) of ribosomal protein S7 (Rps7), a gene that has been implicated in Diamond-Blackfan anemia. Rps7 disruption results in decreased body size, abnormal skeletal morphology, mid-ventral white spotting, and eye malformations. These phenotypes are reported in other murine RP mutants and, as demonstrated for some other RP mutations, are ameliorated by Trp53 deficiency. Interestingly, Rps7 mutants have additional overt malformations of the developing central nervous system and deficits in working memory, phenotypes that are not reported in murine or human RP gene mutants. Conversely, Rps7 mouse mutants show no anemia or hyperpigmentation, phenotypes associated with mutation of human RPS7 and other murine RPs, respectively. We provide two novel RP mouse models and expand the repertoire of potential phenotypes that should be examined in RP mutants to further explore the concept of RP gene-specific phenotypes.
Subject(s)
Anemia, Diamond-Blackfan , Central Nervous System , Morphogenesis/genetics , Ribosomal Proteins/genetics , Anemia, Diamond-Blackfan/genetics , Anemia, Diamond-Blackfan/pathology , Animals , Body Size/genetics , Central Nervous System/growth & development , Central Nervous System/pathology , Disease Models, Animal , Humans , Memory, Short-Term/physiology , Mice , Mutation , Phenotype , Ribosomal Proteins/physiology , Ribosomes/geneticsABSTRACT
Psychiatric genetics has been hampered by the fact that initially exciting findings from underpowered studies are so often not replicated in larger, more powerful, data sets. Here we show that the claims of Zhou et al. that neuropeptide Y (NPY) diplotype-predicted expression is correlated with trait anxiety (neuroticism) is not replicated in a data set consisting of phenotypically extreme individuals drawn from a large (n = 88,142) non-clinical population. We found no association between NPY diplotype or diplotype-predicted expression and neuroticism. Our reply to Zhou and colleagues forms part of a larger debate (see, for example, http://www.nature.com/news/2008/080709/full/454154a.html) about the efficacy and replicability of candidate driven versus genome wide approaches to psychiatric genetics.
Subject(s)
Neuropeptide Y/genetics , Neurotic Disorders/genetics , Genotype , Humans , Polymorphism, Single Nucleotide/genetics , Reproducibility of ResultsABSTRACT
Tobin and Logue (1994) have proposed that interspecific differences in rates of delay discounting are driven by differences in metabolic rates. This "metabolic hypothesis" argues that under conditions of deprivation impulsive animals will out-compete self-controlled animals. The authors report here a series of modeling experiments testing the predictions of Tobin and Logue (1994) using a simulated population of "mice" in which the average meal size, the standard deviation of the meal size, collection risk and maximum delay were parametrically manipulated. The authors found that for all meal size averages and standard deviations self-controlled "mice" out-competed impulsive "mice" and that this advantage was most marked under conditions of deprivation. Conversely, increasing collection risk or maximum delay promoted the dominance of impulsive strategies. These results call into question the "metabolic hypothesis" and suggest that interspecific differences in collection risk may drive differences in rates of delay discounting.
Subject(s)
Appetitive Behavior , Competitive Behavior , Computer Simulation , Feeding Behavior , Food Deprivation , Mice/psychology , Animals , Basal Metabolism , Choice Behavior , Decision Making , Impulsive Behavior/psychology , Motivation , Probability LearningABSTRACT
We recently described methods for estimating the number of N-ethyl-N-nitrosourea (ENU)-induced coding mutations in phenotypic and genotypic screens. In this article we revisit these methods, clarifying their application. In particular, we focus on the difference between unconditional and conditional probabilities. We also introduce a website to assist investigators in the application of these equations ( http://www.well.ox.ac.uk/enuMutRat ).
Subject(s)
Ethylnitrosourea/pharmacology , Genetic Testing/methods , Mutation , Genotype , Mutagenesis , Phenotype , ProbabilityABSTRACT
BACKGROUND: Binocular rivalry is a complex process characterised by alternations in perceptual suppression and dominance that result when two different images are presented simultaneously to the left and right eyes. It has been reported recently that the addition of contextual cues will promote the predominance of the context consistent rivalry target. In contrast to Levelt's second proposition (1965), this effect has been found to result exclusively from an increase in the dominance phase duration, while the suppression phase duration remains unaffected. METHODS: Human subjects were simultaneously presented with a small (2 degrees ) disc consisting of gratings (four cycles per degree) of different orientations to the two eyes. Four experiments were conducted to ascertain the effects of background gratings and contextual colour information on target predominance and phase duration. For each of the four experimental conditions, the orientation and colour of the target gratings and surrounding contextual background were systematically manipulated. RESULTS: In this study, we report an effect opposite to that of Levelt. Contradictory contextual information increases target predominance and phase duration during binocular rivalry. Our results demonstrate that it is possible to promote the dominance of the context contradictory percept with co-linearity, co-chromaticity and orientation cues. In line with previous studies involving context, we find that this effect on predominance is due to an increase in the duration of the dominance rather than the suppression phase. DISCUSSION: We discuss our findings in respect to those from previous studies and consider high- and low-level processes that may be responsible for these apparently 'contradictory' roles of context on binocular rivalry. In addition, we discuss how the apparent 'anti-Levelt' effect of context can be reinterpreted in a manner that brings it back in line with Levelt's second proposition and raises the question of whether 'suppressability' plays a disproportionately large role in determining the duration of perceptual phases in binocular rivalry.